TrialIntensive care medicine2018

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial.

Bruno François et al.PubMed ↗Publisher ↗

No numbers read from the abstract.